Mi Hye Kwon Selected Research

N- (3- isopropyl- 3- ((4- (4- (trifluoromethyl)pyridin- 2- yl)piperazin- 1- yl)carbonyl)cyclopentyl)- 3- methoxytetrahydro- 2H- pyran- 4- amine

1/2018

Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mi Hye Kwon Research Topics

Disease

3	Hyperlipidemias (Hyperlipidemia) 05/2019 - 01/2013
3	Inflammation (Inflammations) 03/2018 - 01/2017
3	Insulin Resistance 03/2018 - 01/2017
2	Penile Induration (Peyronie's Disease) 10/2020 - 05/2018
1	Non-alcoholic Fatty Liver Disease 03/2020
1	Fibrosis (Cirrhosis) 03/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2018
1	Body Weight (Weight, Body) 01/2018
1	Obesity 01/2018
1	Glucose Intolerance 01/2018
1	Neoplasms (Cancer) 01/2017
1	Macular Degeneration (Age-Related Maculopathy) 06/2014

Drug/Important Bio-Agent (IBA)

3	Poloxamer (Poloxamer 407)IBA 05/2019 - 01/2013
2	Pharmaceutical PreparationsIBA 03/2020 - 05/2019
2	Multidrug Resistance-Associated Protein 2IBA 03/2020 - 09/2016
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2020 - 09/2016
2	LipidsIBA 05/2019 - 03/2018
2	AntioxidantsIBA 03/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 01/2017
1	Activin Receptors (Activin Receptor)IBA 10/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2020
1	Therapeutic UsesIBA 10/2020
1	vactosertibIBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	Transforming Growth Factor-beta Type I ReceptorIBA 10/2020
1	EnzymesIBA 03/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2020
1	Orotic AcidIBA 03/2020
1	Small Interfering RNA (siRNA)IBA 05/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2018
1	CreatinineIBA 03/2018
1	Protein Hydrolysates FDA Link 03/2018
1	AlbuminsIBA 03/2018
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Proteins (Proteins, Gene)FDA Link 03/2018
1	Chemokine ReceptorsIBA 01/2018
1	N- (3- isopropyl- 3- ((4- (4- (trifluoromethyl)pyridin- 2- yl)piperazin- 1- yl)carbonyl)cyclopentyl)- 3- methoxytetrahydro- 2H- pyran- 4- amineIBA 01/2018
1	CC ChemokinesIBA 01/2017
1	mangostinIBA 01/2017
1	ATP-Binding Cassette Sub-Family B Member 4IBA 09/2016
1	7-O-succinyl macrolactin AIBA 06/2014
1	macrolactin AIBA 06/2014
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2013
1	Chlorzoxazone FDA LinkGeneric 01/2013

Therapy/Procedure

1	Transplantation 03/2020
1	Oral Administration 03/2020
1	Liver Transplantation 03/2020
1	Drug Therapy (Chemotherapy) 05/2019
1	Aftercare (After-Treatment) 01/2018